Doxanthrine: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
== Doxanthrine == | |||
[[File:Doxanthrine_Structure.svg|thumb|right|Chemical structure of Doxanthrine]] | |||
Doxanthrine | '''Doxanthrine''' is a synthetic compound that acts as a selective agonist for the [[dopamine receptor]] D1. It is primarily used in research settings to study the effects of D1 receptor activation in the [[central nervous system]]. | ||
== Pharmacology == | == Pharmacology == | ||
Doxanthrine is | Doxanthrine is known for its high affinity and selectivity towards the [[dopamine receptor]] D1 subtype. This selectivity makes it a valuable tool in neuropharmacological research, allowing scientists to investigate the specific roles of D1 receptors in various physiological and pathological processes. | ||
== | === Mechanism of Action === | ||
Doxanthrine | Doxanthrine binds to the D1 receptor, a [[G protein-coupled receptor]] (GPCR), and activates it. This activation leads to the stimulation of [[adenylate cyclase]], increasing the levels of [[cyclic adenosine monophosphate]] (cAMP) within the cell. The rise in cAMP levels triggers a cascade of intracellular events that ultimately result in the modulation of neuronal activity. | ||
== | == Applications in Research == | ||
Doxanthrine is utilized in various research studies to explore the role of D1 receptors in the brain. It has been used to: | |||
* Investigate the involvement of D1 receptors in [[cognitive function]] and [[memory]] processes. | |||
* Study the effects of D1 receptor activation in [[neurodegenerative diseases]] such as [[Parkinson's disease]]. | |||
* Examine the potential therapeutic applications of D1 receptor agonists in treating [[psychiatric disorders]] like [[schizophrenia]] and [[depression]]. | |||
== Safety and Toxicity == | |||
As a research chemical, the safety and toxicity profile of Doxanthrine in humans is not well-established. Studies in animal models are typically conducted to assess its pharmacokinetics and potential side effects. Researchers handling Doxanthrine must adhere to appropriate safety protocols to minimize any risks associated with its use. | |||
== Related pages == | |||
[[ | * [[Dopamine receptor]] | ||
[[ | * [[G protein-coupled receptor]] | ||
[[ | * [[Neuropharmacology]] | ||
[[ | * [[Parkinson's disease]] | ||
[[Category:Dopamine receptor agonists]] | |||
[[Category:Research chemicals]] | |||
Latest revision as of 11:06, 15 February 2025
Doxanthrine[edit]
Doxanthrine is a synthetic compound that acts as a selective agonist for the dopamine receptor D1. It is primarily used in research settings to study the effects of D1 receptor activation in the central nervous system.
Pharmacology[edit]
Doxanthrine is known for its high affinity and selectivity towards the dopamine receptor D1 subtype. This selectivity makes it a valuable tool in neuropharmacological research, allowing scientists to investigate the specific roles of D1 receptors in various physiological and pathological processes.
Mechanism of Action[edit]
Doxanthrine binds to the D1 receptor, a G protein-coupled receptor (GPCR), and activates it. This activation leads to the stimulation of adenylate cyclase, increasing the levels of cyclic adenosine monophosphate (cAMP) within the cell. The rise in cAMP levels triggers a cascade of intracellular events that ultimately result in the modulation of neuronal activity.
Applications in Research[edit]
Doxanthrine is utilized in various research studies to explore the role of D1 receptors in the brain. It has been used to:
- Investigate the involvement of D1 receptors in cognitive function and memory processes.
- Study the effects of D1 receptor activation in neurodegenerative diseases such as Parkinson's disease.
- Examine the potential therapeutic applications of D1 receptor agonists in treating psychiatric disorders like schizophrenia and depression.
Safety and Toxicity[edit]
As a research chemical, the safety and toxicity profile of Doxanthrine in humans is not well-established. Studies in animal models are typically conducted to assess its pharmacokinetics and potential side effects. Researchers handling Doxanthrine must adhere to appropriate safety protocols to minimize any risks associated with its use.
